Form 4 holding
Chief Development Officer
PLUS THERAPEUTICS, INC.
- Security class
- Common Stock
- Shares / value
- 0
- Estimated value
- $0
- Report date
- 20 Apr 2026
- Price
- $0.1626
- Ownership
- Direct
Eric Joseph Daniels - Chief Development Officer at PLUS THERAPEUTICS, INC.
Issuer-level insider activity
- Role
- Chief Development Officer
- Issuer ticker
- PSTV on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Eric Joseph Daniels since 01 Aug 2025
Reported holdings for Eric Joseph Daniels in PLUS THERAPEUTICS, INC.
Form 4 holding
Chief Development Officer
PLUS THERAPEUTICS, INC.
- Security class
- Restricted Stock Units
- Shares / value
- 20,000
- Estimated value
- Report date
- 20 Apr 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Development Officer
PLUS THERAPEUTICS, INC.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 20,000
- Estimated value
- Report date
- 20 Apr 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Eric Joseph Daniels in PLUS THERAPEUTICS, INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.